The Effect of Therapeutic Hypothermia After Cardiac Arrest on the Haemostasis.
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- University of Aarhus
- Enrollment
- 82
- Locations
- 2
- Primary Endpoint
- Clotting time in seconds, EXTEM
Study Overview
Brief Summary
This is a sub-study to the Time-differentiated Therapeutic Hypothermia (TTH48, ClinicalTrials.gov Identifier: NCT01689077). TTH48 compares 24 with 48 hours of therapeutic hypothermia at a target temperature of 32-34°C in survivors of out-of-hospital cardiac arrest.
The overall aim of this sub-study is to examine the hemostasis in patients resuscitated after cardiac arrest and treated with 24 and 48 hours of therapeutic hypothermia
Our specific aims are:
- To investigate the whole blood coagulation using the rotational thromboelastometry.
- To investigate the function of platelets
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Out of hospital cardiac arrest of presumed cardiac cause
- •Return of spontaneous circulation (ROSC)
- •Glasgow Coma Score < 8
- •Age > 18 years and < 80 years
Exclusion Criteria
- •> 60 minutes from the circulatory collapse to ROSC
- •Time interval > 4 hours from cardiac arrest to initiation of therapeutic hypothermia
- •Terminal illness
- •Coagulation disorder
- •Unwitnessed asystolia
- •Cerebral performance category 3-4 before the cardiac arrest
- •Severe persistent cardiogenic shock
- •Pregnancy
- •Persistent cardiogenic shock (systolic blood pressure < 80 despite inotropic treatment)
- •New apoplexy or intracerebral hemorrhage
- •Lack of consent from the relatives
- •Lack of consent from the GP
- •Lack of consent from the patient if he/she wakes up and is relevant
Outcomes
Primary Outcomes
Clotting time in seconds, EXTEM
Time Frame: After 46 hours
Measured by thomboelastometry on the ROTEM®
Area under the curve, COL-test
Time Frame: After 46 hours
Platelet function will be measured using Multiplate®
Secondary Outcomes
- Clot formation time in seconds, -EXTEM, INTEM, FIBTEM and HEPTEM(After 22 hours, 46 hours and 70 hours)
- Maximum clot firmness (mm), -EXTEM, INTEM, FIBTEM and HEPTEM(After 22 hours, 46 hours and 70 hours)
- Area under the curve, COL-test(After 22 hours and 70 hours)
- Clotting time in seconds, EXTEM(After 22 hours and 70 hours)
- Clotting time in seconds, -INTEM, FIBTEM and HEPTEM(After 22 hours, 46 hours and 70 hours)
- Maximum velocity (mm/min), -EXTEM, INTEM, FIBTEM and HEPTEM(After 22 hours, 46 hours and 70 hours)
- Area under the curve,- ADP, ASPI and TRAP-test.(After 22 hours, 46 hours and 70 hours)
- Time to maximum velocity (s), -EXTEM, INTEM, FIBTEM and HEPTEM(After 22 hours, 46 hours and 70 hours)
- Area under the curve, Clot stability test(After 22 hours, 46 hours and 70 hours)
- Area under the curve, Thrombin generation(After 22 hours, 46 hours and 70 hours)
